Vivek Kaimal

Vivek Kaimal is an accomplished professional in the field of bioinformatics, currently serving as Executive Director and Head of Translational Bioinformatics at Allogene Therapeutics since January 2021, after previously holding the position of Sr. Director in Translational Sciences. Prior experience includes serving as Director and Head of Bioinformatics and Computational Biology at Rheos Medicines, Inc., and roles at AbbVie, Regulus Therapeutics, Third Rock Ventures, Cincinnati Children's Hospital Medical Center, Brainvisa Technologies, and as a trainee programmer. Vivek Kaimal has a strong background in drug discovery, biomarker identification, data integration, and statistical analysis, with a PhD in Biomedical Engineering/Bioinformatics from the University of Cincinnati and a B.Eng in Computer Engineering from Savitribai Phule Pune University.